On August 8, 2024, Biocon Limited, a global biopharmaceutical company driven by innovation, released its consolidated financial results for the first quarter of the fiscal year ending June 30, 2024. In the first quarter of FY25, Biocon Limited reported a consolidated revenue of ₹4,567 crore. The company made a net investment of ₹228 crore in …